FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hermann Wetzel

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Schizophrenic Psychology

Procedures

Co-author Network

Publications

TOP 3
Matthias J Müller; Armin Scheurich; Hermann Wetzel; Armin Szegedi; Martin Hautzinger
Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: application to alcoholism research.
Martin Hautzinger; Hermann Wetzel; Armin Szegedi; Armin Scheurich; Bernd Lörch; P Singer; D Schläfke; Helmut Sittinger; Thomas Wobrock; Matthias J Müller; I Anghelescu
[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].
Hermann Wetzel; Armin Szegedi; Armin Scheurich; Bernd Lörch; Peter Singer; Detlef Schläfke; Helmut Sittinger; Thomas Wobrock; Matthias J Müller; Ion Anghelescu; Martin Hautzinger
Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hermann Wetzel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Matthias J Müller; Armin Scheurich; Hermann Wetzel; Armin Szegedi; Martin Hautzinger
Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: application to alcoholism research.
Alcohol and alcoholism (Oxford, Oxfordshire) 2005;40(2):124-31.
2005: Martin Hautzinger; Hermann Wetzel; Armin Szegedi; Armin Scheurich; Bernd Lörch; P Singer; D Schläfke; Helmut Sittinger; Thomas Wobrock; Matthias J Müller; I Anghelescu
[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].
Der Nervenarzt 2005;76(3):295-307.
2004: Hermann Wetzel; Armin Szegedi; Armin Scheurich; Bernd Lörch; Peter Singer; Detlef Schläfke; Helmut Sittinger; Thomas Wobrock; Matthias J Müller; Ion Anghelescu; Martin Hautzinger
Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.
The Journal of clinical psychiatry 2004;65(10):1406-13.
2004: Matthias J Müller; Wolfgang Rossbach; Klaus Mann; Joachim Röschke; Florian Müller-Siecheneder; M Blümler; Hermann Wetzel; H Russ; Ralf W Dittmann; Otto Benkert
Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms.
Pharmacopsychiatry 2004;37(4):157-62.
2003: Christian Lange-Asschenfeldt; Matthias J Müller; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Hermann Wetzel
Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis.
European addiction research 2003;9(1):1-7.
2002: Matthias J Müller; Hermann Wetzel; Franz-Xaver Eich; Werner Rein; Alain Puech; Otto Benkert
Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
Journal of clinical psychopharmacology 2002;22(6):554-60.
2002: Matthias J Müller; Hermann Wetzel; Otto Benkert
Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis.
International clinical psychopharmacology 2002;17(5):249-61.
2001: Ion Anghelescu; Sabine Germeyer; Matthias J Müller; Christoph Klawe; Peter Singer; Norbert Dahmen; Hermann Wetzel; Hubertus Himmerich; Armin Szegedi
No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria.
Alcoholism, clinical and experimental research 2001;25(6):805-9.
2001: Norbert Dahmen; Matthias J Müller; Sabine Germeyer; Dan Rujescu; I Anghelescu; Christoph Hiemke; Hermann Wetzel
Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients.
Schizophrenia research 2001;49(1-2):223-5.
2001: M J Müller; Armin Szegedi; Hermann Wetzel; Otto Benkert
Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression.
Schizophrenia bulletin 2001;27(1):19-28.
2000: Armin Scheurich; Matthias J Müller; Hermann Wetzel; Ion Anghelescu; Christoph Klawe; A Ruppe; Bernd Lörch; Hubertus Himmerich; M Heidenreich; G Schmid; Martin Hautzinger; Armin Szegedi
Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).
Journal of studies on alcohol 2000;61(6):916-9.
2000: Matthias J Müller; Armin Szegedi; Hermann Wetzel; Otto Benkert
Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale.
Journal of affective disorders 2000;60(2):137-40.
2000: Norbert Dahmen; T Pauly; Armin Szegedi; Hermann Wetzel; Ion Anghelescu; K Ferdinand; Christoph Hiemke
Adenylyl cyclase activity is increased in younger, but decreased in older, alcoholic patients after detoxification.
Alcohol and alcoholism (Oxford, Oxfordshire) 2000;35(3):249-54.
2000: Ralf Schlösser; Hermann Wetzel; H Dörr; Wolfgang Rossbach; Christoph Hiemke; Otto Benkert
Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers.
Psychoneuroendocrinology 2000;25(4):377-88.
2000: Armin Szegedi; Matthias J Müller; Hubertus Himmerich; Ion Anghelescu; Hermann Wetzel
Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patients.
Alcoholism, clinical and experimental research 2000;24(4):497-500.
2000: Matthias J Müller; Wolfgang Rossbach; Eugen Davids; Hermann Wetzel; Otto Benkert
[Evaluation of standardized training for the "Positive and Negative Syndrome Scale" (PANSS)].
Der Nervenarzt 2000;71(3):195-204.
2000: Armin Szegedi; Bernd Lörch; Armin Scheurich; A Ruppe; Martin Hautzinger; Hermann Wetzel
Cue exposure in alcohol dependent patients: preliminary evidence for different types of cue reactivity.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(6):721-30.
1999: Matthias J Müller; Gerhard Gründer; Hermann Wetzel; Florian Müller-Siecheneder; P Marx-Dannigkeit; Otto Benkert
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial.
Psychiatry research 1999;89(3):275-80.
1999: M J Müller; Hermann Wetzel; Armin Szegedi; Otto Benkert
Three dimensions of depression in patients with acute psychotic disorders: a replication study.
Comprehensive psychiatry 1999;40(6):449-57.
1999: Matthias J Müller; P Marx-Dannigkeit; Ralf Schlösser; Hermann Wetzel; D Addington; Otto Benkert
The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).
Journal of psychiatric research 1999;33(5):433-43.
1999: Gerhard Gründer; Matthias J Müller; J Andreas; N Heydari; Hermann Wetzel; Ralf Schlösser; S Schlegel; Otmar Nickel; D Eissner; Otto Benkert
Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.
Psychopharmacology 1999;146(1):81-6.
1999: Armin Szegedi; Ion Anghelescu; J Wiesner; S Schlegel; Harald Weigmann; Sebastian Härtter; Christoph Hiemke; Hermann Wetzel
Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial.
Pharmacopsychiatry 1999;32(4):148-53.
1999: T Pauly; Norbert Dahmen; Armin Szegedi; Hermann Wetzel; G F Böl; K Ferdinand; Christoph Hiemke
Blood ethanol levels and adenylyl cyclase activity in lymphocytes of alcoholic patients.
Biological psychiatry 1999;45(4):489-93.
1999: Gerhard Gründer; Hermann Wetzel; Ralf Schlösser; Ion Anghelescu; A Hillert; K Lange; Christoph Hiemke; Otto Benkert
Neuroendocrine response to antipsychotics: effects of drug type and gender.
Biological psychiatry 1999;45(1):89-97.
1998: Ion Anghelescu; Armin Szegedi; S Schlegel; Harald Weigmann; Christoph Hiemke; Hermann Wetzel
Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(4):315-20.
1998: Armin Szegedi; Ion Anghelescu; T Pauly; Norbert Dahmen; Matthias J Müller; Hermann Wetzel; Christoph Hiemke
Activity of the adenylyl cyclase in lymphocytes of male alcoholic patients is state dependent.
Alcoholism, clinical and experimental research 1998;22(9):2073-9.
1998: Matthias J Müller; Hermann Wetzel
Dimensionality of depression in acute schizophrenia: a methodological study using the Bech-Rafaelsen Melancholia Scale (BRMES).
Journal of psychiatric research 1998;32(6):369-78.
1998: Sebastian Härtter; Hermann Wetzel; E Hammes; M Torkzadeh; Christoph Hiemke
Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trial.
Pharmacopsychiatry 1998;31(5):199-200.
1998: Matthias J Müller; Wolfgang Rossbach; P Dannigkeit; Florian Müller-Siecheneder; Armin Szegedi; Hermann Wetzel
Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS).
Schizophrenia research 1998;32(3):151-60.
1998: M J Müller; Hermann Wetzel
Improvement of inter-rater reliability of PANSS items and subscales by a standardized rater training.
Acta psychiatrica Scandinavica 1998;98(2):135-9.
1998: Sebastian Härtter; Hermann Wetzel; E Hammes; M Torkzadeh; Christoph Hiemke
Nonlinear pharmacokinetics of fluvoxamine and gender differences.
Therapeutic drug monitoring 1998;20(4):446-9.
1998: Hermann Wetzel; Gerhard Gründer; A Hillert; M Philipp; Wagner Farid Gattaz; H Sauer; G Adler; J Schröder; Werner Rein; Otto Benkert
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
Psychopharmacology 1998;137(3):223-32.
1998: Eugen Davids; Gerhard Gründer; Hermann Wetzel; Otto Benkert
[Psychopharmacotherapy in pregnancy and breast feeding].
Fortschritte der Neurologie-Psychiatrie 1998;66(5):207-24.
1998: Florian Müller-Siecheneder; Matthias J Müller; A Hillert; Armin Szegedi; Hermann Wetzel; Otto Benkert
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.
Journal of clinical psychopharmacology 1998;18(2):111-20.
1998: Hermann Wetzel; Ion Anghelescu; Armin Szegedi; J Wiesner; Harald Weigmann; S Härter; Christoph Hiemke
Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
Journal of clinical psychopharmacology 1998;18(1):2-9.
1997: Armin Szegedi; Hermann Wetzel; D Angersbach; M Philipp; Otto Benkert
Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.
Journal of affective disorders 1997;45(3):167-78.
1997: Armin Szegedi; Hermann Wetzel; D Angersbach; G C Dunbar; H Schwarze; M Philipp; Otto Benkert
A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
Pharmacopsychiatry 1997;30(3):97-105.
1997: Otto Benkert; Armin Szegedi; Hermann Wetzel; H J Staab; W Meister; M Philipp
Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.
Acta psychiatrica Scandinavica 1997;95(4):288-96.
1996: Otto Benkert; Gerhard Gründer; Hermann Wetzel; david Hackett
A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.
Journal of psychiatric research 1996;30(6):441-51.
1996: Otto Benkert; Armin Szegedi; Hermann Wetzel
Minimum effective dose for antidepressants--an obligatory requirement for antidepressant drug evaluation?
International clinical psychopharmacology 1996;11(3):177-85.
1996: Klaus Mann; H Bauer; Christoph Hiemke; Joachim Röschke; Hermann Wetzel; Otto Benkert
Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1996;6(3):163-8.
1996: Armin Szegedi; Hermann Wetzel; M Leal; Sebastian Härtter; Christoph Hiemke
Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
The Journal of clinical psychiatry 1996;57(6):257-64.
1996: Gerhard Gründer; Hermann Wetzel; Ralf Schlösser; Otto Benkert
Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
Pharmacopsychiatry 1996;29(2):72-8.
1995: H Gerbaldo; M P Fickinger; Hermann Wetzel; A Helisch; M Philipp; Otto Benkert
Primary enduring negative symptoms in schizophrenia and major depression.
Journal of psychiatric research 1995;29(4):297-302.
1995: Hermann Wetzel; Armin Szegedi; C Hain; J Wiesner; S Schlegel; Otto Benkert
Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.
Psychopharmacology 1995;119(2):231-8.
1995: Gerhard Gründer; Hermann Wetzel; A Hillert; E Jochum; Christoph Hiemke; Otto Benkert
The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.
Psychopharmacology 1995;117(4):472-8.
1995: Otto Benkert; Florian Müller-Siecheneder; Hermann Wetzel
Dopamine agonists in schizophrenia: a review.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():43-53.
1994: W Seiler; Hermann Wetzel; A Hillert; G Schöllnhammer; M Langer; U Barlage; Christoph Hiemke
Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application.
Psychopharmacology 1994;116(4):457-63.
1994: Hermann Wetzel; A Hillert; Gerhard Gründer; Otto Benkert
Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms.
The American journal of psychiatry 1994;151(10):1499-502.
1994: Hermann Wetzel; J Wiesner; Christoph Hiemke; Otto Benkert
Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers.
Journal of psychiatric research 1994;28(5):461-73.
1994: Christoph Hiemke; Harald Weigmann; Sebastian Härtter; Norbert Dahmen; Hermann Wetzel; H Müller
Elevated levels of clozapine in serum after addition of fluvoxamine.
Journal of clinical psychopharmacology 1994;14(4):279-81.
1994: W Seiler; Hermann Wetzel; A Hillert; G Schöllnhammer; Otto Benkert; Christoph Hiemke
Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients.
Experimental and clinical endocrinology 1994;102(4):326-33.
1993: Otto Benkert; Hermann Wetzel; Armin Szegedi
Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
International clinical psychopharmacology 1993;8 Suppl 1():3-14.
1993: Hermann Wetzel; Otto Benkert
Dopamine autoreceptor agonists in the treatment of schizophrenic disorders.
Progress in neuro-psychopharmacology & biological psychiatry 1993;17(4):525-40.
1993: Gerhard Gründer; Hermann Wetzel; E Hammes; Otto Benkert
Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression.
Psychopharmacology 1993;111(1):123-6.
1993: Sebastian Härtter; Hermann Wetzel; E Hammes; Christoph Hiemke
Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients.
Psychopharmacology 1993;110(3):302-8.
1992: Otto Benkert; Gerhard Gründer; Hermann Wetzel
Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression.
Pharmacopsychiatry 1992;25(6):254-60.
1992: Sebastian Härtter; Hermann Wetzel; Christoph Hiemke
Automated determination of fluvoxamine in plasma by column-switching high-performance liquid chromatography.
Clinical chemistry 1992;38(10):2082-6.
1992: A Hillert; W Maier; Hermann Wetzel; Otto Benkert
Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
Pharmacopsychiatry 1992;25(5):213-7.
1991: Hermann Wetzel; U von Bardeleben; Florian Holsboer; Otto Benkert
[Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
Fortschritte der Neurologie-Psychiatrie 1991;59 Suppl 1():23-9.
1991: A Gerken; Hermann Wetzel; Otto Benkert
Extrapyramidal symptoms and their relationship to clinical efficacy under perphenazine treatment. A controlled prospective handwriting-test study in 22 acutely ill schizophrenic patients.
Pharmacopsychiatry 1991;24(4):132-7.
1991: S Süss; W Seiler; Christoph Hiemke; G Schöllnhammer; Hermann Wetzel; A Hillert
Determination of benperidol and its reduced metabolite in human plasma by high-performance liquid chromatography and electrochemical detection.
Journal of chromatography 1991;565(1-2):363-73.
1991: Hermann Wetzel; Klaus Wiedemann; Florian Holsboer; Otto Benkert
Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patients.
Psychopharmacology 1991;103(2):280-3.
1988: Hermann Wetzel; I Heuser; Otto Benkert
Benzodiazepines for catatonic symptoms, stupor, and mutism.
Pharmacopsychiatry 1988;21(6):394-5.
1988: W Maier; M Philipp; I Heuser; S Schlegel; R Buller; Hermann Wetzel
Improving depression severity assessment--I. Reliability, internal validity and sensitivity to change of three observer depression scales.
Journal of psychiatric research 1988;22(1):3-12.
1987: Hermann Wetzel; I Heuser; O Benkert
Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788.
The Journal of nervous and mental disease 1987;175(4):240-2.